Clinical Spectrum of COVID-19 Patients after Vaccination

Asif Niaz; Muhammad Tahir Younas; Shaista Nayyar; Sabeeha Yousaf; Zainab Rizwan; Ainan Arshad

doi:10.51253/pafmj.v72i6.7323

Clinical Spectrum of COVID-19 Patients after Vaccination

Asif Niaz, Muhammad Tahir Younas, Shaista Nayyar, Sabeeha Yousaf, Zainab Rizwan, Ainan Arshad

Section of Internal Medicine, Department of Medicine, Medical College, Pakistan

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: To examine the clinical severity and magnitude of COVID-19 patients after the second dose of the COVID-19 vaccine. Study Design: Cross-sectional study. Place and Duration of Study: Tertiary Care Hospital, Islamabad Pakistan, from Feb to Jun 2021. Methodology: The individuals who had two doses of the vaccine (dead inactivated-Vero Cell) and got COVID-19 at least two weeks after vaccination were included in the study. These patients were divided into Mild, Moderate and Severe categories based on their symptoms and Investigations. Results: Out of 5000 individuals vaccinated, 225(4.5%) got infected with COVID-19 later. Among these 225, 172(76.4%) had mild symptoms and recovered, with only 1(0.4%) death was reported. Conclusion: COVID-19 vaccination does not infer 100% immunity, but if someone gets infected with COVID after vaccination, there are remarkable chances of recovery.

Original language	English (US)
Pages (from-to)	1990-1993
Number of pages	4
Journal	Pakistan Armed Forces Medical Journal
Volume	72
Issue number	6
DOIs	https://doi.org/10.51253/pafmj.v72i6.7323
Publication status	Published - Dec 2022

Keywords

COVID-19 vaccine
Post-vaccine infection
Severe disease

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.51253/pafmj.v72i6.7323

Cite this

@article{73f1f8142964435abf7f574cc45d9dd1,

title = "Clinical Spectrum of COVID-19 Patients after Vaccination",

abstract = "Objective: To examine the clinical severity and magnitude of COVID-19 patients after the second dose of the COVID-19 vaccine. Study Design: Cross-sectional study. Place and Duration of Study: Tertiary Care Hospital, Islamabad Pakistan, from Feb to Jun 2021. Methodology: The individuals who had two doses of the vaccine (dead inactivated-Vero Cell) and got COVID-19 at least two weeks after vaccination were included in the study. These patients were divided into Mild, Moderate and Severe categories based on their symptoms and Investigations. Results: Out of 5000 individuals vaccinated, 225(4.5\%) got infected with COVID-19 later. Among these 225, 172(76.4\%) had mild symptoms and recovered, with only 1(0.4\%) death was reported. Conclusion: COVID-19 vaccination does not infer 100\% immunity, but if someone gets infected with COVID after vaccination, there are remarkable chances of recovery.",

keywords = "COVID-19 vaccine, Post-vaccine infection, Severe disease",

author = "Asif Niaz and Younas, \{Muhammad Tahir\} and Shaista Nayyar and Sabeeha Yousaf and Zainab Rizwan and Ainan Arshad",

year = "2022",

month = dec,

doi = "10.51253/pafmj.v72i6.7323",

language = "English (US)",

volume = "72",

pages = "1990--1993",

journal = "Pakistan Armed Forces Medical Journal",

issn = "0030-9648",

publisher = "Army Medical College",

number = "6",

}

TY - JOUR

T1 - Clinical Spectrum of COVID-19 Patients after Vaccination

AU - Niaz, Asif

AU - Younas, Muhammad Tahir

AU - Nayyar, Shaista

AU - Yousaf, Sabeeha

AU - Rizwan, Zainab

AU - Arshad, Ainan

PY - 2022/12

Y1 - 2022/12

N2 - Objective: To examine the clinical severity and magnitude of COVID-19 patients after the second dose of the COVID-19 vaccine. Study Design: Cross-sectional study. Place and Duration of Study: Tertiary Care Hospital, Islamabad Pakistan, from Feb to Jun 2021. Methodology: The individuals who had two doses of the vaccine (dead inactivated-Vero Cell) and got COVID-19 at least two weeks after vaccination were included in the study. These patients were divided into Mild, Moderate and Severe categories based on their symptoms and Investigations. Results: Out of 5000 individuals vaccinated, 225(4.5%) got infected with COVID-19 later. Among these 225, 172(76.4%) had mild symptoms and recovered, with only 1(0.4%) death was reported. Conclusion: COVID-19 vaccination does not infer 100% immunity, but if someone gets infected with COVID after vaccination, there are remarkable chances of recovery.

AB - Objective: To examine the clinical severity and magnitude of COVID-19 patients after the second dose of the COVID-19 vaccine. Study Design: Cross-sectional study. Place and Duration of Study: Tertiary Care Hospital, Islamabad Pakistan, from Feb to Jun 2021. Methodology: The individuals who had two doses of the vaccine (dead inactivated-Vero Cell) and got COVID-19 at least two weeks after vaccination were included in the study. These patients were divided into Mild, Moderate and Severe categories based on their symptoms and Investigations. Results: Out of 5000 individuals vaccinated, 225(4.5%) got infected with COVID-19 later. Among these 225, 172(76.4%) had mild symptoms and recovered, with only 1(0.4%) death was reported. Conclusion: COVID-19 vaccination does not infer 100% immunity, but if someone gets infected with COVID after vaccination, there are remarkable chances of recovery.

KW - COVID-19 vaccine

KW - Post-vaccine infection

KW - Severe disease

UR - https://www.scopus.com/pages/publications/85145322987

U2 - 10.51253/pafmj.v72i6.7323

DO - 10.51253/pafmj.v72i6.7323

M3 - Article

AN - SCOPUS:85145322987

SN - 0030-9648

VL - 72

SP - 1990

EP - 1993

JO - Pakistan Armed Forces Medical Journal

JF - Pakistan Armed Forces Medical Journal

IS - 6

ER -

Clinical Spectrum of COVID-19 Patients after Vaccination

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this